Meng-Ya Chang

589 total citations
8 papers, 448 citations indexed

About

Meng-Ya Chang is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Meng-Ya Chang has authored 8 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Hematology. Recurrent topics in Meng-Ya Chang's work include Genomics, phytochemicals, and oxidative stress (3 papers), Glycosylation and Glycoproteins Research (1 paper) and Bioactive Compounds and Antitumor Agents (1 paper). Meng-Ya Chang is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (3 papers), Glycosylation and Glycoproteins Research (1 paper) and Bioactive Compounds and Antitumor Agents (1 paper). Meng-Ya Chang collaborates with scholars based in Taiwan and United States. Meng-Ya Chang's co-authors include Chao‐Liang Wu, Ai‐Li Shiau, Chrong‐Reen Wang, Dong‐Hwang Chen, Yu‐Hung Chen, Chen‐Hsi Chou, Tomor Harnod, Yu‐Cheng Chou, Jing‐Gung Chung and Hsu-Tung Lee and has published in prestigious journals such as The Journal of Immunology, Antimicrobial Agents and Chemotherapy and Molecules.

In The Last Decade

Meng-Ya Chang

8 papers receiving 440 citations

Peers

Meng-Ya Chang
Joana Lopes Portugal
Soo Ah Park South Korea
Leah Gandee United States
Seulki Lee South Korea
Meng-Ya Chang
Citations per year, relative to Meng-Ya Chang Meng-Ya Chang (= 1×) peers Marwa M. Afifi

Countries citing papers authored by Meng-Ya Chang

Since Specialization
Citations

This map shows the geographic impact of Meng-Ya Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng-Ya Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng-Ya Chang more than expected).

Fields of papers citing papers by Meng-Ya Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng-Ya Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng-Ya Chang. The network helps show where Meng-Ya Chang may publish in the future.

Co-authorship network of co-authors of Meng-Ya Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Meng-Ya Chang. A scholar is included among the top collaborators of Meng-Ya Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng-Ya Chang. Meng-Ya Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Wang, Chung-Teng, Jia‐Ming Chang, Yi‐Ting Yen, et al.. (2025). OCT4 promotes lung cancer progression through upregulation of VEGF-correlated chemokine-1. International Journal of Medical Sciences. 22(3). 680–695. 6 indexed citations
2.
Chou, Yu‐Cheng, Meng-Ya Chang, Hsu-Tung Lee, et al.. (2018). Phenethyl Isothiocyanate Inhibits In Vivo Growth of Xenograft Tumors of Human Glioblastoma Cells. Molecules. 23(9). 2305–2305. 16 indexed citations
3.
Chou, Yu‐Cheng, Meng-Ya Chang, Mei-Jen Wang, et al.. (2015). PEITC induces apoptosis of Human Brain Glioblastoma GBM8401 Cells through the extrinsic- and intrinsic -signaling pathways. Neurochemistry International. 81. 32–40. 44 indexed citations
4.
Chou, Yu‐Cheng, Meng-Ya Chang, Mei-Jen Wang, et al.. (2015). PEITC inhibits human brain glioblastoma GBM 8401 cell migration and invasion through the inhibition of uPA, Rho A, and Ras with inhibition of MMP-2, -7 and -9 gene expression. Oncology Reports. 34(5). 2489–2496. 31 indexed citations
5.
Yang, Mei-Lin, Yu-Chu Su, Yi-Cheng Chen, et al.. (2015). Kallistatin Ameliorates Influenza Virus Pathogenesis by Inhibition of Kallikrein-Related Peptidase 1-Mediated Cleavage of Viral Hemagglutinin. Antimicrobial Agents and Chemotherapy. 59(9). 5619–5630. 16 indexed citations
6.
Shieh, Gia-Shing, Yu-Chu Su, Che‐Hsin Lee, et al.. (2012). Acquisition of an enhanced aggressive phenotype in human lung cancer cells selected by suboptimal doses of cisplatin following cell deattachment and reattachment. Cancer Letters. 321(1). 36–44. 15 indexed citations
7.
Chen, Yu‐Hung, Meng-Ya Chang, Chen‐Hsi Chou, et al.. (2007). Methotrexate Conjugated to Gold Nanoparticles Inhibits Tumor Growth in a Syngeneic Lung Tumor Model. Molecular Pharmaceutics. 4(5). 713–722. 299 indexed citations
8.
Shiau, Ai‐Li, Shih‐Yao Chen, Meng-Ya Chang, et al.. (2007). Prothymosin α Lacking the Nuclear Localization Signal as an Effective Gene Therapeutic Strategy in Collagen-Induced Arthritis. The Journal of Immunology. 178(7). 4688–4694. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026